These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32325487)

  • 21. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.
    González F; Sia CL; Shepard MK; Rote NS; Minium J
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4071-9. PubMed ID: 22904174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. At the crossroads of fertility and metabolism: the importance of AMPK-dependent signaling in female infertility associated with hyperandrogenism.
    Froment P; Plotton I; Giulivi C; Fabre S; Khoueiry R; Mourad NI; Horman S; Ramé C; Rouillon C; Grandhaye J; Bigot Y; Chevaleyre C; Le Guevel R; Mallegol P; Andriantsitohaina R; Guerif F; Tamburini J; Viollet B; Foretz M; Dupont J
    Hum Reprod; 2022 May; 37(6):1207-1228. PubMed ID: 35459945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years.
    Fernandez RC; Moore VM; Rumbold AR; Whitrow MJ; Avery JC; Davies MJ
    Hum Reprod; 2021 Jul; 36(8):2275-2284. PubMed ID: 33963388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of circulating microRNAs miR-142-3p and miR-598-3p in women with polycystic ovary syndrome as potential diagnostic markers.
    Insenser M; Quintero A; de Lope S; Álvarez-Blasco F; Martínez-García MÁ; Luque-Ramírez M; Escobar-Morreale HF
    Hum Reprod; 2023 May; 38(5):951-960. PubMed ID: 36931262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
    Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derailed peripheral circadian genes in polycystic ovary syndrome patients alters peripheral conversion of androgens synthesis.
    Johnson BS; Krishna MB; Padmanabhan RA; Pillai SM; Jayakrishnan K; Laloraya M
    Hum Reprod; 2022 Jul; 37(8):1835-1855. PubMed ID: 35728080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
    Sam S; Scoccia B; Yalamanchi S; Mazzone T
    Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
    Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
    Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salicylate administration suppresses the inflammatory response to nutrients and improves ovarian function in polycystic ovary syndrome.
    González F; Mather KJ; Considine RV; Abdelhadi OA; Acton AJ
    Am J Physiol Endocrinol Metab; 2020 Oct; 319(4):E744-E752. PubMed ID: 32830548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic β-cell dysfunction in polycystic ovary syndrome.
    Malin SK; Kirwan JP; Sia CL; González F
    J Clin Endocrinol Metab; 2014 Jan; 99(1):322-9. PubMed ID: 24203060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro.
    Piltonen TT; Chen JC; Khatun M; Kangasniemi M; Liakka A; Spitzer T; Tran N; Huddleston H; Irwin JC; Giudice LC
    Hum Reprod; 2015 May; 30(5):1203-15. PubMed ID: 25750105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resting energy expenditure in women with polycystic ovary syndrome.
    Tosi F; Rosmini F; Gremes V; Lucarini F; Zandonà M; Zanolin ME; Fiers T; Kaufman JM; Moghetti P
    Hum Reprod; 2024 Aug; 39(8):1794-1803. PubMed ID: 38867472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome.
    Chen MJ; Han DS; Yang JH; Yang YS; Ho HN; Yang WS
    Hum Reprod; 2012 Aug; 27(8):2476-83. PubMed ID: 22693174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls.
    Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
    Biol Sex Differ; 2023 Sep; 14(1):62. PubMed ID: 37736753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation.
    Malin SK; Kirwan JP; Sia CL; González F
    Am J Physiol Endocrinol Metab; 2015 May; 308(9):E770-7. PubMed ID: 25714674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
    Ollila MM; West S; Keinänen-Kiukaanniemi S; Jokelainen J; Auvinen J; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen LC
    Hum Reprod; 2017 Feb; 32(2):423-431. PubMed ID: 28031324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 24-hour movement behaviours and cardiometabolic markers in women with polycystic ovary syndrome (PCOS): a compositional data analysis.
    Pesonen E; Farrahi V; Brakenridge CJ; Ollila MM; Morin-Papunen LC; Nurkkala M; Jämsä T; Korpelainen R; Moran LJ; Piltonen TT; Niemelä M
    Hum Reprod; 2024 Dec; 39(12):2830-2847. PubMed ID: 39366675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    J Endocrinol; 2006 Mar; 188(3):521-9. PubMed ID: 16522732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.